In the respiratory system, CXCL7 has been found to be significantly elevated 29 months prior to lung cancer development, making it the first blood biomarker capable of diagnosing stage 0 cancer (Yee et al., 2009; Lee et al., 2011; Ulivi et al., 2013). Here, PPBP is linked to cancer.